Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

http://scihub22266oqcxt.onion/ 32348055!ä!32348055       Rev+Med+Suisse 2020 ; 16 (N degrees 691-2): 863-868 Nephropedia Template TP {{tp|p=32348055|t=2020. COVID-19 : Prise en charge aux soins intensifs |pdf=|usr=}}{{32348055}} gab.com Text COVID-19 : Prise en charge aux soins intensifs JO: Rev Med Suisse http://www.kidney.de/pget.php?&tw=1&pmid=32348055 #FOAvip The SARS-coronavirus 2 disease initially reported in December 2019 in China (COVID-19) represents a major challenge for intensive care medicine, due to the high number of ICU admission and the prolonged stay for many patients. Up to 5 % of COVID-19 infected patients develop severe acute hypoxemic respiratory failure requiring invasive mechanical ventilation as supportive treatment. Apart from early antiviral and anti-inflammatory treatment, the management of COVID-19 patients is mainly applying protective mechanical ventilation, to support the injured lungs. However recently acquired data and clinical experience suggest that COVID-19-related ARDS presents some specificities that will be summarized in the present article. Twit Text FOAVip COVID-19 : Prise en charge aux soins intensifs ????Rev Med Suisse http://www.kidney.de/pget.php?&tw=1&pmid=32348055 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32348055 #FOAvip English Wikipedia <ref>{{Cite pmid|32348055}}</ref> COVID-19 : Prise en charge aux soins intensifs #MMPMID32348055 Krahenbuhl M; Oddo M; Piquilloud L; Pantet O Rev Med Suisse 2020[Apr]; 16 (N degrees 691-2): 863-868 PMID32348055show ga The SARS-coronavirus 2 disease initially reported in December 2019 in China (COVID-19) represents a major challenge for intensive care medicine, due to the high number of ICU admission and the prolonged stay for many patients. Up to 5 % of COVID-19 infected patients develop severe acute hypoxemic respiratory failure requiring invasive mechanical ventilation as supportive treatment. Apart from early antiviral and anti-inflammatory treatment, the management of COVID-19 patients is mainly applying protective mechanical ventilation, to support the injured lungs. However recently acquired data and clinical experience suggest that COVID-19-related ARDS presents some specificities that will be summarized in the present article. |*Betacoronavirus[MESH] |*Coronavirus Infections/complications/epidemiology[MESH] |*Critical Care[MESH] |*Pandemics[MESH] |*Pneumonia, Viral/complications/epidemiology[MESH] |COVID-19[MESH] |China[MESH] |Humans[MESH] |Respiration, Artificial[MESH]COVID-19 : Prise en charge aux soins intensifs (epmc).pdf DeepDyve Pubget Overpricing